313 related articles for article (PubMed ID: 26647312)
1. De novo dominant ASXL3 mutations alter H2A deubiquitination and transcription in Bainbridge-Ropers syndrome.
Srivastava A; Ritesh KC; Tsan YC; Liao R; Su F; Cao X; Hannibal MC; Keegan CE; Chinnaiyan AM; Martin DM; Bielas SL
Hum Mol Genet; 2016 Feb; 25(3):597-608. PubMed ID: 26647312
[TBL] [Abstract][Full Text] [Related]
2. [Bainbridge-Ropers syndrome with ASXL3 gene variation in a child and literature review].
Zhang R; He XH; Lin HY; Yang XH
Zhonghua Er Ke Za Zhi; 2018 Feb; 56(2):138-141. PubMed ID: 29429203
[No Abstract] [Full Text] [Related]
3. Novel splicing mutation in the ASXL3 gene causing Bainbridge-Ropers syndrome.
Hori I; Miya F; Ohashi K; Negishi Y; Hattori A; Ando N; Okamoto N; Kato M; Tsunoda T; Yamasaki M; Kanemura Y; Kosaki K; Saitoh S
Am J Med Genet A; 2016 Jul; 170(7):1863-7. PubMed ID: 27075689
[TBL] [Abstract][Full Text] [Related]
4. Bainbridge-Ropers syndrome caused by loss-of-function variants in ASXL3: a recognizable condition.
Kuechler A; Czeschik JC; Graf E; Grasshoff U; Hüffmeier U; Busa T; Beck-Woedl S; Faivre L; Rivière JB; Bader I; Koch J; Reis A; Hehr U; Rittinger O; Sperl W; Haack TB; Wieland T; Engels H; Prokisch H; Strom TM; Lüdecke HJ; Wieczorek D
Eur J Hum Genet; 2017 Feb; 25(2):183-191. PubMed ID: 27901041
[TBL] [Abstract][Full Text] [Related]
5. Further expanding the clinical phenotype in Bainbridge-Ropers syndrome and dissecting genotype-phenotype correlation in the ASXL3 mutational cluster regions.
Yu KP; Luk HM; Fung JLF; Chung BH; Lo IF
Eur J Med Genet; 2021 Jan; 64(1):104107. PubMed ID: 33242595
[TBL] [Abstract][Full Text] [Related]
6. Modeling Bainbridge-Ropers Syndrome in
Lichtig H; Artamonov A; Polevoy H; Reid CD; Bielas SL; Frank D
Front Physiol; 2020; 11():75. PubMed ID: 32132929
[TBL] [Abstract][Full Text] [Related]
7. Delineating the phenotypic spectrum of Bainbridge-Ropers syndrome: 12 new patients with
Balasubramanian M; Willoughby J; Fry AE; Weber A; Firth HV; Deshpande C; Berg JN; Chandler K; Metcalfe KA; Lam W; Pilz DT; Tomkins S
J Med Genet; 2017 Aug; 54(8):537-543. PubMed ID: 28100473
[TBL] [Abstract][Full Text] [Related]
8. Familial Bainbridge-Ropers syndrome: Report of familial ASXL3 inheritance and a milder phenotype.
Schirwani S; Woods E; Koolen DA; Ockeloen CW; Lynch SA; Kavanagh K; Graham JM; Grand K; Pierson TM; Chung JM; Balasubramanian M
Am J Med Genet A; 2023 Jan; 191(1):29-36. PubMed ID: 36177608
[TBL] [Abstract][Full Text] [Related]
9. De novo nonsense variant in ASXL3 in a Chinese girl causing Bainbridge-Ropers syndrome: A case report and review of literature.
Wang Q; Zhang J; Jiang N; Xie J; Yang J; Zhao X
Mol Genet Genomic Med; 2022 May; 10(5):e1924. PubMed ID: 35276034
[TBL] [Abstract][Full Text] [Related]
10. Expanding the phenotype of ASXL3-related syndrome: A comprehensive description of 45 unpublished individuals with inherited and de novo pathogenic variants in ASXL3.
Schirwani S; Albaba S; Carere DA; Guillen Sacoto MJ; Milan Zamora F; Si Y; Rabin R; Pappas J; Renaud DL; Hauser N; Reid E; Blanchet P; Foulds N; Dixit A; Fisher R; Armstrong R; Isidor B; Cogne B; Schrier Vergano S; Demirdas S; Dykzeul N; Cohen JS; Grand K; Morel D; Slavotinek A; Albassam HF; Naik S; Dean J; Ragge N; Costa C; Tedesco MG; Harrison RE; Bouman A; Palen E; Challman TD; Willemsen MH; Vogt J; Cunniff C; Bergstrom K; Walia JS; Bruel AL; Kini U; Alkuraya FS; Slegesky V; Meeks N; Girotto P; Johnson D; ; Newbury-Ecob R; Ockeloen CW; Prontera P; Lynch SA; Li D; Graham JM; Pierson TM; Balasubramanian M
Am J Med Genet A; 2021 Nov; 185(11):3446-3458. PubMed ID: 34436830
[TBL] [Abstract][Full Text] [Related]
11. Case report : a novel ASXL3 gene variant in a Sudanese boy.
Wu K; Cong Y
BMC Pediatr; 2021 Dec; 21(1):557. PubMed ID: 34886823
[TBL] [Abstract][Full Text] [Related]
12. Identification and functional characterization of de novo FOXP1 variants provides novel insights into the etiology of neurodevelopmental disorder.
Sollis E; Graham SA; Vino A; Froehlich H; Vreeburg M; Dimitropoulou D; Gilissen C; Pfundt R; Rappold GA; Brunner HG; Deriziotis P; Fisher SE
Hum Mol Genet; 2016 Feb; 25(3):546-57. PubMed ID: 26647308
[TBL] [Abstract][Full Text] [Related]
13. Bainbridge-ropers syndrome caused by loss-of-function variants in ASXL3: Clinical abnormalities, medical imaging features, and gene variation in infancy of case report.
Yang L; Guo B; Zhu W; Wang L; Han B; Che Y; Guo L
BMC Pediatr; 2020 Jun; 20(1):287. PubMed ID: 32517662
[TBL] [Abstract][Full Text] [Related]
14. Novel compound heterozygous
Giri D; Rigden D; Didi M; Peak M; McNamara P; Senniappan S
Int J Pediatr Endocrinol; 2017; 2017():8. PubMed ID: 28785287
[TBL] [Abstract][Full Text] [Related]
15. ASXL3-related disorder: Molecular phenotyping and comprehensive review providing insights into disease mechanism.
Woods E; Holmes N; Albaba S; Evans IR; Balasubramanian M
Clin Genet; 2024 May; 105(5):470-487. PubMed ID: 38420660
[TBL] [Abstract][Full Text] [Related]
16. A de novo nonsense mutation in
Koboldt DC; Mihalic Mosher T; Kelly BJ; Sites E; Bartholomew D; Hickey SE; McBride K; Wilson RK; White P
Cold Spring Harb Mol Case Stud; 2018 Jun; 4(3):. PubMed ID: 29305346
[TBL] [Abstract][Full Text] [Related]
17. [Diagnosis of Bainbridge-Ropers syndrome due to de novo ASXL3 variant by high throughput sequencing].
Lyu Y; Zhao D; Zhang K; Gao M; Ma J; Wang D; Gai Z; Liu Y
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Apr; 37(4):452-454. PubMed ID: 32219835
[TBL] [Abstract][Full Text] [Related]
18. Rare germline heterozygous missense variants in BRCA1-associated protein 1, BAP1, cause a syndromic neurodevelopmental disorder.
Küry S; Ebstein F; Mollé A; Besnard T; Lee MK; Vignard V; Hery T; Nizon M; Mancini GMS; Giltay JC; Cogné B; McWalter K; Deb W; Mor-Shaked H; Li H; Schnur RE; Wentzensen IM; Denommé-Pichon AS; Fourgeux C; Verheijen FW; Faurie E; Schot R; Stevens CA; Smits DJ; Barr E; Sheffer R; Bernstein JA; Stimach CL; Kovitch E; Shashi V; Schoch K; Smith W; van Jaarsveld RH; Hurst ACE; Smith K; Baugh EH; Bohm SG; Vyhnálková E; Ryba L; Delnatte C; Neira J; Bonneau D; Toutain A; Rosenfeld JA; ; Audebert-Bellanger S; Gilbert-Dussardier B; Odent S; Laumonnier F; Berger SI; Smith ACM; Bourdeaut F; Stern MH; Redon R; Krüger E; Margueron R; Bézieau S; Poschmann J; Isidor B
Am J Hum Genet; 2022 Feb; 109(2):361-372. PubMed ID: 35051358
[TBL] [Abstract][Full Text] [Related]
19. De Novo Truncating Variants in ASXL2 Are Associated with a Unique and Recognizable Clinical Phenotype.
Shashi V; Pena LD; Kim K; Burton B; Hempel M; Schoch K; Walkiewicz M; McLaughlin HM; Cho M; Stong N; Hickey SE; Shuss CM; ; Freemark MS; Bellet JS; Keels MA; Bonner MJ; El-Dairi M; Butler M; Kranz PG; Stumpel CT; Klinkenberg S; Oberndorff K; Alawi M; Santer R; Petrovski S; Kuismin O; Korpi-Heikkilä S; Pietilainen O; Aarno P; Kurki MI; Hoischen A; Need AC; Goldstein DB; Kortüm F
Am J Hum Genet; 2016 Oct; 99(4):991-999. PubMed ID: 27693232
[TBL] [Abstract][Full Text] [Related]
20. ASXL3 De Novo Variant-Related Neurodevelopmental Disorder Presenting as Dystonic Cerebral Palsy.
Švantnerová J; Minár M; Radová S; Kolníková M; Vlkovič P; Zech M
Neuropediatrics; 2022 Oct; 53(5):361-365. PubMed ID: 35863334
[No Abstract] [Full Text] [Related]
[Next] [New Search]
